Premium
Transcatheter aortic valve replacement (TAVR) as bridge therapy restoring eligibility for liver transplantation in cirrhotic patients
Author(s) -
Levy Clementine,
Lassailly Guillaume,
El Amrani Mehdi,
Vincent Flavien,
Delhaye Cedric,
Meurice Thibault,
Boleslawski Emmanuel,
Millet Guillaume,
Ningarhari Massih,
Truant Stephanie,
Louvet Alexandre,
Mathurin Philippe,
Lebuffe Gilles,
Pruvot FrançoisRené,
Dharancy Sébastien
Publication year - 2020
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.15955
Subject(s) - medicine , contraindication , valve replacement , stenosis , transplantation , aortic valve replacement , surgery , liver transplantation , cardiology , aortic valve stenosis , aortic valve , alternative medicine , pathology
Severe aortic stenosis is a widespread valve disease, constituting a contraindication to organ transplantation due to cardiovascular morbidity and projected mortality. Mortality after conventional surgical aortic valve replacement in cirrhotic patients depends upon the Child–Pugh class. In the past few years, transcatheter aortic valve replacement has progressively become the treatment of choice for high‐risk patients with severe aortic stenosis. Here, we report the cases of 3 cirrhotic patients who became eligible for liver transplantation after successful transcatheter aortic valve replacement as bridge therapy.